Ashok Kumar Balaraman
Overview
Explore the profile of Ashok Kumar Balaraman including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
48
Citations
24
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lingamaiah D, Bushi G, Gaidhane S, Balaraman A, Padmapriya G, Kaur I, et al.
BMC Geriatr
. 2025 Mar;
25(1):179.
PMID: 40089681
Background: Falls represent a significant health concern among the older adults, particularly geriatric cancer patients, due to their increased susceptibility from both age-related and cancer treatment-related factors. This systematic review...
2.
Soni M, Khatib M, Balaraman A, Roopashree R, Kaur M, Srivastava M, et al.
J Epidemiol Glob Health
. 2025 Mar;
15(1):43.
PMID: 40080234
Background: Neonatal disorders represent a significant public health challenge, particularly in low- and middle-income countries, where they account for 79% of global neonatal mortality. South Asia, comprising countries such as...
3.
Yappalparvi A, Khatib M, Balaraman A, Rekha M, Kaur M, Sharma G, et al.
AIDS Res Ther
. 2025 Mar;
22(1):31.
PMID: 40057788
Background: Vaccine acceptance among People Living with HIV (PLWH) is crucial for managing and mitigating the spread of infectious diseases, including Mpox. This systematic review and meta-analysis assess the rate...
4.
Balaraman A, Babu M, Afzal M, Sanghvi G, M M R, Gupta S, et al.
Regen Ther
. 2025 Mar;
28:558-572.
PMID: 40034540
Recently, increasing interest has been in utilizing mesenchymal stem cell-derived extracellular vesicles (MSC-EVs), especially exosomes, as nanocarriers for miRNA delivery in cancer treatment. Due to such characteristics, nanocarriers are specific:...
5.
Singh M, Balaraman A, Mehta R, Sah S
New Microbes New Infect
. 2025 Feb;
63:101515.
PMID: 39981225
No abstract available.
6.
Bushi G, Gaidhane S, Balaraman A, Padmapriya G, Kaur I, Lal M, et al.
J Geriatr Oncol
. 2025 Feb;
16(3):102202.
PMID: 39955892
Introduction: Falls are a significant health concern among older adults, particularly those with cancer, due to aging-related frailty, treatment-related adverse effects, and comorbidities. Existing reviews have highlighted the burden of...
7.
Kumar V, Singh M, Khatib M, Balaraman A, Roopashree R, Kaur M, et al.
Expert Rev Respir Med
. 2025 Feb;
:1-9.
PMID: 39917855
Background: Chronic obstructive pulmonary disease (COPD) is a leading cause of morbidity and mortality globally, particularly in low- and middle-income countries like India. This study aims to analyze regional trends...
8.
Rohilla S, Gaidhane S, Balaraman A, Padmapriya G, Kaur I, Lal M, et al.
J Infect Dis
. 2025 Feb;
PMID: 39913333
Background: Recent outbreaks of monkeypox (Mpox) have raised concerns about its complications, including ophthalmic manifestations such as conjunctivitis, keratitis, and potential vision impairment. The lack of comprehensive data on these...
9.
Balaraman A, Afzal M, Moglad E, Babu M, Priya G, Bansal P, et al.
Biogerontology
. 2025 Feb;
26(2):50.
PMID: 39907830
p16INK4a is a crucial tumor suppressor and regulator of cellular senescence, forming a molecular bridge between aging and cancer. Dysregulated p16INK4a expression is linked to both premature aging and cancer...
10.
Malvi A, Khatib M, Balaraman A, Roopashree R, Kaur M, Srivastava M, et al.
BMC Pulm Med
. 2025 Jan;
25(1):48.
PMID: 39881272
Background: Cannabis is the third most widely used psychoactive substance globally, and its consumption has been increasing, particularly with the growing trend of legalization for medicinal and recreational use. Recent...